Intensive lipid lowering with atorvastatin in coronary disease

N Engl J Med. 2005 Jul 7;353(1):93-6; author reply 93-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atorvastatin
  • Cardiovascular Diseases / prevention & control*
  • Coronary Disease / drug therapy*
  • Heptanoic Acids / administration & dosage
  • Heptanoic Acids / adverse effects*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Mortality
  • Pyrroles / administration & dosage
  • Pyrroles / adverse effects*
  • Rhabdomyolysis / chemically induced

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Atorvastatin